E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/23/2016 in the Prospect News Bank Loan Daily.

Usana extends revolver, temporarily ups availability to $125 million

By Wendy Van Sickle

Columbus, Ohio, Feb. 23 – Usana Health Sciences, Inc. extended its revolving credit agreement with Bank of America, NA and temporarily increased commitments by $50 million to $125 million on Friday, according to an 8-K filing with the Securities and Exchange Commission.

Revolving commitments will revert to $75 million on Oct. 31. 2016 under the amended and restated credit agreement, which now matures April 27, 2021.

Additionally, the amendment increased Usana’s rolling four-quarter consolidated EBITDA covenant to $100 million from $60 million.

The credit agreement is originally dated April 27, 2011.

Other terms and provisions were not changed, the filing said.

Usana is a Salt Lake City-based developer, manufacturer and distributor of nutritional and personal-care products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.